Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Jeffrey M Gelfand"'
Autor:
Valerie J Block, Kanishka Koshal, Jaeleene Wijangco, Nicolette Miller, Narender Sara, Kyra Henderson, Jennifer Reihm, Arpita Gopal, Sonam D Mohan, Jeffrey M Gelfand, Chu-Yueh Guo, Lauren Oommen, Alyssa Nylander, James A Rowson, Ethan Brown, Stephen Sanders, Katherine Rankin, Courtney R Lyles, Ida Sim, Riley Bove
Publikováno v:
JMIR Human Factors, Vol 11, p e49331 (2024)
BackgroundFalls are common in people with multiple sclerosis (MS), causing injuries, fear of falling, and loss of independence. Although targeted interventions (physical therapy) can help, patients underreport and clinicians undertreat this issue. Pa
Externí odkaz:
https://doaj.org/article/c622acf5e90546f889255e9bac8f0e72
Autor:
Andrew L Mammen, Jarushka Naidoo, Divyanshu Dubey, Michael Dougan, Teilo H Schaller, Meghan J Mooradian, Douglas B Johnson, Jorg Dietrich, Leyre Zubiri, Tomas G Neilan, Bianca D Santomasso, Ryan J Sullivan, Kerry L Reynolds, Allison Betof Warner, Justine V Cohen, Nancy Wang, Jenny Linnoila, Jeffrey M Gelfand, Anthony A Amato, Stacey L Clardy, David A Reardon, William C Louv, Amanda C Guidon, Leeann B Burton, Bart K Chwalisz, James Hillis, Priscilla K Brastianos, Tracey A Cho, Christopher T Doughty, Jeffrey T Guptill, Vern C Juel, Robert Kadish, Noah Kolb, Nicole R LeBoeuf, Maria Martinez-Lage, Krista M Rubin, Karin Woodman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Expanding the US Food and Drug Administration–approved indications for immune checkpoint inhibitors in patients with cancer has resulted in therapeutic success and immune-related adverse events (irAEs). Neurologic irAEs (irAE-Ns) have an incidence
Externí odkaz:
https://doaj.org/article/a2206707f599451b8603379684ad2015
Autor:
Brent D Fulton, David G Proudman, Hannah A Sample, Jeffrey M Gelfand, Charles Y Chiu, Joseph L DeRisi, Michael R Wilson
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0226895 (2020)
OBJECTIVE:To estimate healthcare expenditures that could be impacted by advanced diagnostic testing for patients hospitalized with meningitis or encephalitis. METHODS:Patients hospitalized with meningitis (N = 23,933) or encephalitis (N = 7,858) in t
Externí odkaz:
https://doaj.org/article/1f10d3f0cf1247219f54014c26ec541c
Autor:
Eduardo Caverzasi, Christian Cordano, Alyssa H Zhu, Chao Zhao, Antje Bischof, Gina Kirkish, Daniel J Bennett, Michael Devereux, Nicholas Baker, Justin Inman, Hao H Yiu, Nico Papinutto, Jeffrey M Gelfand, Bruce A C Cree, Stephen L Hauser, Roland G Henry, Ari J Green
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0235615 (2020)
No single neuroimaging technique or sequence is capable of reflecting the functional deficits manifest in MS. Given the interest in imaging biomarkers for short- to medium-term studies, we aimed to assess which imaging metrics might best represent fu
Externí odkaz:
https://doaj.org/article/50f2d42b968541a38bc789831e43ca08
Autor:
Soon-Tae Lee, Hesham Abboud, Sarosh R. Irani, Hideto Nakajima, Amanda L. Piquet, Sean J. Pittock, E. Ann Yeh, Jiawei Wang, Sharmila Rajan, James Overell, Jillian Smith, Jane St Lambert, Muna El-Khairi, Marina Gafarova, Jeffrey M. Gelfand
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
BackgroundAutoimmune encephalitis (AIE) encompasses a spectrum of rare autoimmune-mediated neurological disorders, which are characterized by brain inflammation and dysfunction. Autoantibodies targeting the N-methyl-d-aspartic acid receptor (NMDAR) a
Externí odkaz:
https://doaj.org/article/8e934d562b244ba88ff1f00093c8fd1c
Autor:
Valerie A J Block, Erica Pitsch, Peggy Tahir, Bruce A C Cree, Diane D Allen, Jeffrey M Gelfand
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0154335 (2016)
OBJECTIVE:To perform a systematic review of studies using remote physical activity monitoring in neurological diseases, highlighting advances and determining gaps. METHODS:Studies were systematically identified in PubMed/MEDLINE, CINAHL and SCOPUS fr
Externí odkaz:
https://doaj.org/article/967492ca9d05402698b07631a482e162
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e36847 (2012)
To determine whether retinal axonal loss is detectable in patients with a clinically isolated syndrome (CIS), a first clinical demyelinating attack suggestive of multiple sclerosis (MS), and examine patterns of retinal axonal loss across MS disease s
Externí odkaz:
https://doaj.org/article/db90fa112eeb49aa849b06c695af9006
Autor:
Valerie J. Block, Matthew Waliman, Zhendong Xie, Amit Akula, Riley Bove, Mark J. Pletcher, Gregory M. Marcus, Jeffrey E. Olgin, Bruce A. C. Cree, Jeffrey M. Gelfand, Roland G. Henry
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
BackgroundAmbulatory disability is common in people with multiple sclerosis (MS). Remote monitoring using average daily step count (STEPS) can assess physical activity (activity) and disability in MS. STEPS correlates with conventional metrics such a
Externí odkaz:
https://doaj.org/article/887429b042884014a72a8c7df5bf4b94
Autor:
Colin R. Zamecnik, Gavin M. Sowa, Ahmed Abdelhak, Ravi Dandekar, Rebecca D. Bair, Kristen J. Wade, Christopher M. Bartley, Asritha Tubati, Refujia Gomez, Camille Fouassier, Chloe Gerungan, Jessica Alexander, Anne E. Wapniarski, Rita P. Loudermilk, Erica L. Eggers, Kelsey C. Zorn, Kirtana Ananth, Nora Jabassini, Sabrina A. Mann, Nicholas R. Ragan, Adam Santaniello, Roland G. Henry, Sergio E. Baranzini, Scott S. Zamvil, Riley M. Bove, Chu-Yueh Guo, Jeffrey M. Gelfand, Richard Cuneo, H.-Christian von Büdingen, Jorge R. Oksenberg, Bruce AC Cree, Jill A. Hollenbach, Ari J. Green, Stephen L. Hauser, Mitchell T. Wallin, Joseph L. DeRisi, Michael R. Wilson
Publikováno v:
medRxiv
Although B cells are implicated in multiple sclerosis (MS) pathophysiology, a predictive or diagnostic autoantibody remains elusive. Here, the Department of Defense Serum Repository (DoDSR), a cohort of over 10 million individuals, was used to genera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ac96b2bbc77aa7d1a7a685cce7b501a
https://europepmc.org/articles/PMC10187343/
https://europepmc.org/articles/PMC10187343/
Autor:
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R. Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L. Bennett, H.-Christian von Büdingen, Robert Carruthers, Keith R. Edwards, Robert Fallis, Paul S. Giacomini, Benjamin M. Greenberg, David A. Hafler, Carolina Ionete, Ulrike W. Kaunzner, Christopher B. Lock, Erin E. Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S. Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M. Gelfand, Anne H. Cross, Briana Cameron, Bruno Musch, Ryan C. Winger, Xiaoming Jia, Christopher T. Harp, Ann Herman, Amit Bar-Or
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, vol 120, iss 3
A small proportion of multiple sclerosis (MS) patients develop new disease activity soon after starting anti-CD20 therapy. This activity does not recur with further dosing, possibly reflecting deeper depletion of CD20-expressing cells with repeat inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::384a4285b60b8efee3e53099aac80957
https://escholarship.org/uc/item/2nb3w4bz
https://escholarship.org/uc/item/2nb3w4bz